Top Markets
#1 Derive Derive +31.84%
#2 Cross Cross +12.72%
#3 The Bitcoin Bull The Bitcoin Bull +10.86%
#4 Audiera Audiera +10.69%
#5 Gama Token Gama Token +9.20%
#6 Geodnet Geodnet +8.99%
#7 Velvet Velvet +7.84%
#8 Based Based +7.78%
#9 Biconomy Biconomy +7.61%
#10 Starpower Starpower +7.59%
Coin of the day
Derive Derive
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Dogwood Therapeutics, Inc. Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc.

DWTX
Rang in Aktien #35719
Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to... Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions provoked by viral infections. Its leading therapeutic candidate, IMC-1, is a precise fixed-dose combination of famciclovir and celecoxib, engineered to combat fibromyalgia. Additionally, the company is advancing IMC-2, which blends valacyclovir and celecoxib, aiming to alleviate the array of symptoms linked to long COVID, including persistent fatigue, sleep disturbances, cognitive issues, pain, autonomic dysfunction, and anxiety. Previously operating as Virios Therapeutics, Inc., the organization adopted the name Dogwood Therapeutics, Inc. in October 2024. Established in 2012, the company maintains its main office in Alpharetta, Georgia.
Aktienkurs
$1.84
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$3.51M
Veränderung (1 Tag)
0.46%
Veränderung (1 Jahr)
-62.71%
Land
US
Handel Dogwood Therapeutics, Inc. (DWTX)

Kategorie

Healthcare
EPS für Dogwood Therapeutics, Inc. (DWTX)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Dogwood Therapeutics, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Dogwood Therapeutics, Inc. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE